Dr Reddys Laboratories Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹8,753.40 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 0.85 per cent from ₹8,828.30 crore. This corresponds to a year-on-year *(YoY) growth of 4.44 per cent.
Operating Profit
Operating Profit stands at ₹365.50 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 13.16 per cent from ₹420.90 crore. This corresponds to a year-on-year *(YoY) growth of 54.81 per cent.
PBDT
PBDT stands at ₹874.60 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 4.16 per cent from ₹912.60 crore. This corresponds to a year-on-year *(YoY) decline of 7.11 per cent.
Profit Before Tax
Profit Before Tax stands at ₹1,543.20 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 11.55 per cent from ₹1,744.80 crore. This corresponds to a year-on-year *(YoY) decline of 17.67 per cent.
Net Profit
Net Profit stands at ₹1,209.90 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 10.18 per cent from ₹1,347.10 crore. This represents a 14.42 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Dr Reddys Laboratories Ltd News
Dr Reddys Laboratories Ltd Earnings
- YOY
- QOQ
Dr Reddys Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Dr Reddys Laboratories Ltd Research Reports
Dr Reddys Laboratories Ltd Financial Reports
Dr Reddys Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Dr Reddy's Labs | -1.19% | 0.96% | 3.41% | 2.27% | 2.99% | 3.39% |
| Divi's Lab. | 0.63% | 0.30% | -5.14% | -5.59% | 3.25% | 3.16% |
| Torrent Pharma. | 1.89% | 2.53% | 3.18% | 6.57% | 12.28% | 32.99% |
| Cipla | -0.03% | 0.71% | -8.45% | -11.70% | -11.74% | -7.43% |
| Lupin | -0.37% | -0.68% | 0.58% | 8.18% | 13.30% | 8.76% |
| Zydus Lifesci. | -3.64% | -2.00% | -0.89% | -6.75% | -7.23% | -5.05% |
| Mankind Pharma | -0.56% | -0.37% | -6.83% | -8.73% | -14.65% | -14.31% |
Company Info
Company Information
Co-Chairman & Managing Director : G V Prasad
Executive Chairman : K Satish Reddy
Independent Director : Shikha Sanjaya Sharma
Independent Director : Leo Puri
Independent Director : K P Krishnan
Independent Director : Pennv Wan
Company Sec. & Compli. Officer : K Randhir Singh
Independent Director : Arun M. Kumar
Independent Director : Claudio Albrecht
Independent Director : Sanjiv Mehta
Independent Director : Alpna Seth